1-Hydroxybenzotriazole → N-Cyclopropyl-4'-(5-{[(cyclopropylacetyl)amino]methyl}-1,3,4-oxadiazol-2-yl)-6-methyl-1,1'-biphenyl-3-carboxamide

HRID 31488

반응식

HRID 31488 반응식
[CH:1]1([CH2:4][C:5]([OH:7])=O)[CH2:3][CH2:2]1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C.[NH2:51][CH2:52][C:53]1[O:57][C:56]([C:58]2[CH:63]=[CH:62][C:61]([C:64]3[C:69]([CH3:70])=[CH:68][CH:67]=[C:66]([C:71]([NH:73][CH:74]4[CH2:76][CH2:75]4)=[O:72])[CH:65]=3)=[CH:60][CH:59]=2)=[N:55][N:54]=1>CN(C=O)C>[CH:74]1([NH:73][C:71]([C:66]2[CH:65]=[C:64]([C:61]3[CH:62]=[CH:63][C:58]([C:56]4[O:57][C:53]([CH2:52][NH:51][C:5](=[O:7])[CH2:4][CH:1]5[CH2:2][CH2:3]5)=[N:54][N:55]=4)=[CH:59][CH:60]=3)[C:69]([CH3:70])=[CH:68][CH:67]=2)=[O:72])[CH2:76][CH2:75]1

참가 물질

7

반응물 5

HCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 138440Cyclopropaneacetic acidHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 99978914'-[5-(aminomethyl)-1,3,4-oxadiazol-2-yl]-N-cyclopropyl-6-methyl-1,1'-biphenyl-3-carboxamide

생성물 1

HCID 11743420N-Cyclopropyl-4'-(5-{[(cyclopropylacetyl)amino]methyl}-1,3,4-oxadiazol-2-yl)-6-methyl-1,1'-biphenyl-3-carboxamide

시약·촉매·용매 1

HCID 6228Dimethylformamide용매2회

실험 절차

Cyclopropylacetic acid (8.6 mg) and HATU (33 mg) in DMF (1 ml) were stirred for 10 minutes at room temperature. To this solution was added HOBt (11.6 mg), DIPEA (.0.45 ml) and 4′-[5-(aminomethyl)-1,3,4-oxadiazol-2-yl]-N-cyclopropyl-6-methyl-1,1′-biphenyl-3-carboxamide (Example 53) (30 mg) in DMF (2 ml) and the reaction stirred at room temperature for 18 hours. The solvent was evaporated under vacuum and the residue dissolved in DCM and washed with water (2×4 ml). The organic phase was reduced to dryness and the residue purified by bond-elut (SCX, 5 g) eluting with methanol and methanolic ammonia. The methanolic ammonia fraction was further purified by preparative HPLC to give, after evaporation of the solvents, N-cyclopropyl-4′-(5-{[(cyclopropylacetyl)amino]methyl}-1,3,4-oxadiazol-2-yl)-6-methyl-1,1′-biphenyl-3-carboxamide.

후처리

  1. customThe solvent was evaporated under vacuum
  2. dissolutionthe residue dissolved in DCM
  3. washwashed with water (2×4 ml)
  4. customthe residue purified by bond-elut (SCX, 5 g)
  5. washeluting with methanol and methanolic ammonia
  6. customThe methanolic ammonia fraction was further purified by preparative HPLC
  7. customto give
  8. customafter evaporation of the solvents, N-cyclopropyl-4′-(5-{[(cyclopropylacetyl)amino]methyl}-1,3,4-oxadiazol-2-yl)-6-methyl-1,1′-biphenyl-3-carboxamide

출처 및 근거

ORD 기록
ord-cee9229187bc4191bddab0d779521d5f
출처 데이터셋
uspto-grants-2008_09
특허 번호
US07425555B2

연결된 노트

불러오는 중…